| Financial Year |
March 31 2023 |
| Monetary Funds |
355,359,287.63 |
| Held-for-trading Financial Assets |
97,309,338.17 |
| Notes Receivable |
20,692,680.98 |
| Accounts Receivable |
117,417,616.51 |
| Advances to Suppliers |
9,606,955.89 |
| Other Receivables |
4,121,744.82 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
154,648,468.61 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,284,480.94 |
| Total Current Assets |
778,273,789.25 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
78,993,016.56 |
| Fixed Assetes |
134,252,733.94 |
| Under-construction Projects |
19,618,703.50 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
18,433,999.78 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
15,402,027.48 |
| Deferred Income Tax Assets |
18,726,890.18 |
| Other Non-Current Assets |
275,119.00 |
| Sub-Total of Non-Current Assets |
296,233,986.37 |
| Total Assets |
1,074,507,775.62 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
30,998,261.50 |
| Accounts Received In Advance |
824,991.45 |
| Employee Compensation Payable |
7,481,039.91 |
| Taxes Payable |
717,450.71 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,986,304.09 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,333,100.89 |
| Other Current Liabilities |
7,178,146.88 |
| Sub-Total of Current Liabilities |
64,086,194.26 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
238,703.03 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
20,217,444.15 |
| Total Liabilities |
84,303,638.41 |
| Paid-In Capital(Or Share Stock) |
151,511,482.00 |
| Capital Surplus |
506,669,559.70 |
| Surplus Reserve |
20,207,064.85 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
297,692,215.41 |
| Minority Stockholder's Interest |
5,405,586.68 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
984,798,550.53 |
| Owner's Equity（Stockholder's Equity） |
990,204,137.21 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,074,507,775.62 |
